Production (Stage)
Camp4 Therapeutics Corporation
CAMP
$2.09
$0.105.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 28.51% | 66.86% | -- | -53.86% | |
| Total Receivables | -- | -75.57% | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | -- | 157.06% | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | 57.59% | -- | -- | |
| Total Current Assets | -- | 65.90% | -- | -- | |
|
|
|||||
| Total Current Assets | -- | 65.90% | -- | -- | |
| Net Property, Plant & Equipment | -- | -22.61% | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | 0.00% | -- | -- | |
| Total Assets | -- | 42.52% | -- | -- | |
|
|
|||||
| Total Accounts Payable | -- | 16.12% | -- | -- | |
| Total Accrued Expenses | -- | 42.58% | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -8.46% | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | 219.03% | -- | -- | |
| Total Other Current Liabilities | -- | 219.03% | -- | -- | |
| Total Current Liabilities | -- | 22.94% | -- | -- | |
|
|
|||||
| Total Current Liabilities | -- | 22.94% | -- | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -35.58% | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | 0.00% | -- | -- | |
| Total Liabilities | -- | -8.26% | -- | -- | |
|
|
|||||
| Common Stock & APIC | -- | 658.71% | -- | -- | |
| Retained Earnings | -- | -32.38% | -- | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 141.68% | 151.03% | -- | -59.59% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | 0.00% | |
|
|
|||||
| Total Common Equity | 141.68% | 151.03% | -- | -59.59% | |
| Total Preferred Equity | -- | -- | -- | 0.00% | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 34.24% | 64.36% | -- | -54.60% | |
|
|
|||||